News

TIME’S UP announced today the launch of TIME’S UP Healthcare, a new affiliate which aims to drive new policies and decisions that result in more balanced, diverse and accountable leadership; address workplace discrimination, harassment and abuse; and create equitable and safe work cultures within all facets of the healthcare industry. TIME’S UP Healthcare is the newest industry affiliate of TIME’S UP, joining a coalition of women across industries dedicated to advancing the organization’s mission of creating safe, fair and dignified work for women of all kinds.

Show Me Your Stethoscope, through our STAMP Out Violence campaign, has striven to raise awareness to the epidemic of violence and harassment that Nurses endure everyday while on the job and has stood by our colleagues, helping to amplify the voice of a Nation of Nurses. We work to address a workplace culture that has come to expect that Nurses will be abused, encouraging all people to speak up and report incidents of physical, verbal and sexual assault. Show Me Your Stethoscope is proud to support TIME’S UP Healthcare’s goal “To unify national efforts to bring safety, equity, and dignity to our healthcare workplace.”

SMYS’ Kelley Muldoon-Rieger MSN PNP and Julia Sierra-Sanchez will be on hand and speaking at the March 1 launch of TIME’S UP Healthcare.

“The new warning will be added to the prescribing information and the patient medication guides for all single and combination agents in the glucose-lowering SGLT2 inhibitor class of drugs approved to treat type 2 diabetes. Those drugs include the following:

Necrotizing fasciitis of the perineum, also called Fournier’s gangrene, is an extremely rare but life-threatening bacterial infection of the tissues underlying the skin surrounding the perineal muscles, nerves, fat, and blood vessels. It is estimated to occur in about 1.6 of 100,000 males annually in the United States, most often among those aged 50 to 79 years (3.3/100,000).

However, from March 2013 to May 2018, the FDA received reports of 12 cases of Fournier’s gangrene among patients taking SGLT2 inhibitors, of whom five were women and seven were men. The condition has rarely been reported among women. The patients ranged in age from 38 to 78 years.”

Read on at Medscape to find out about treatment options and what patients and healthcare professionals should do.